Skip to main content

Home-dropdown-Navigation

  • Tell us what you want to know
    • Smart Transmitter ?
Getting started on eversense cgm just got easier Existing Customers COVID-19 Update

Desktop Top header menu

  • Provider
  • PATIENT
  • Resource Library
    • PAYER RESOURCE LIBRARY
    • PROVIDER RESOURCE LIBRARY
    • PATIENT RESOURCE LIBRARY
Eversense USA   Eversense OUS
Getting started on eversense cgm just got easier Existing Customers COVID-19 Update
Home

Main navigation

  • What Is Eversense?
  • Member Value
  • Evidence
  • Resource Library
  • Reimbursement & Processing
Home

Mobile Main Navigation

  • WHAT IS EVERSENSE
  • MEMBER VALUE
    • Improved Outcomes
    • Quality of Life
    • Device Safety
  • EVIDENCE
    • REAL-WORLD ADHERENCE
    • Importance of Time in Range
    • Product Performance
    • CLINICAL TRIALS
      • 1 | Precise
      • 2 | Precise II
      • 3 | Precision
  • RESOURCE LIBRARY
  • REIMBURSEMENT & PROCESSING

Patient Website
Provider Website

Eversense USA   Eversense OUS

Site Map

Paragraphs
Sitemap
 

SITE MAP

 
 
WHAT IS EVERSENSE?
 
MEMBER VALUE
  • Improved Outcomes
  • Quality of Life
  • Device Safety
EVIDENCE
  • Real-world Adherence
  • Importance of Time in Range
  • Product Performance
  • CLINICAL TRIALS
    • 1 | Precise
    • 2 | Precise II
    • 3 | Precision
REIMBURSEMENT & PROCESSING
REIMBUR-SEMENT & PROCESSING
 
GET SUPPORT
 
Footer Menu
  • EULA
  • Privacy Policy
  • Legal
  • Safety Information
 
Selector Class
sitemap-page-content
x

Right -Fixed Menu Home Page

  • Email
  • Reimbur-sement

Footer top menu

  • Need more information or support?
  • 844-SENSE4U (736-7348)
  • email us
  • Browse our resources

Who we are

Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. Our mission is to help people with diabetes live their lives confidently and with ease.
Learn more

Eversense Diabetes Website

Eversense USA   Eversense OUS

FooterMenu Coloum second

  • What Is Eversense?
  • Member Value
    • Improved Outcomes
    • Quality of Life
    • Device Safety

Footer - Menu Column Three

  • EVIDENCE
    • Real-World Adherence
    • Importance of Time in Range
    • Product Performance
    • CLINICAL TRIALS
      • 1 | Precise
      • 2 | Precise II
      • 3 | Precision

FooterMenu Coloumn third

  • Reimbursement & Processing
  • Resource Library
  • CONTACT US
DISCLAIMER

The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration twice per day, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see https://eversensediabetes.com/safety-info/.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

MKT-001443 Rev01

Footer menu

  • © 2019 Senseonics, Incorporated
  • EULA
  • Privacy Policy
  • Legal
  • Safety
  • Contact Us
  • Site Map